Intrathecal dexmedetomidine versus magnesium sulfate as adjuvant to hyperbaric bupivacaine in total abdominal hysterectomy

Background Different adjuvants have been added to local anesthetics to increase the duration of regional anesthesia, delay onset of postoperative pain, and decrease pain-relieving drugs. The present study aims to compare the effect of adding dexmedetomidine versus magnesium sulfate to intrathecal hy...

Full description

Saved in:
Bibliographic Details
Main Authors: Abeer E Farhat (Author), Mona E Elkafrawy (Author)
Format: Book
Published: Wolters Kluwer Medknow Publications, 2020-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_538ff62d9c1d44a096585d14517aaedb
042 |a dc 
100 1 0 |a Abeer E Farhat  |e author 
700 1 0 |a Mona E Elkafrawy  |e author 
245 0 0 |a Intrathecal dexmedetomidine versus magnesium sulfate as adjuvant to hyperbaric bupivacaine in total abdominal hysterectomy 
260 |b Wolters Kluwer Medknow Publications,   |c 2020-01-01T00:00:00Z. 
500 |a 1687-1693 
500 |a 10.4103/AZMJ.AZMJ_96_19 
520 |a Background Different adjuvants have been added to local anesthetics to increase the duration of regional anesthesia, delay onset of postoperative pain, and decrease pain-relieving drugs. The present study aims to compare the effect of adding dexmedetomidine versus magnesium sulfate to intrathecal hyperbaric bupivacaine in total abdominal hysterectomy regarding onset, duration of sensory and motor blockade, duration of postoperative analgesia, hemodynamic stability, and complications. Patients and methods A prospective randomized double-blind clinical study included 40 women aged 40-56 years, with American Society of Anesthesiologists physical status I and II, scheduled for total abdominal hysterectomy. They were randomly divided into two groups: group I (n=20) got 15 mg of 0.5% hyperbaric bupivacaine in addition to 10 μg dexmedetomidine, whereas group II (n=20) got 15 mg of 0.5% hyperbaric bupivacaine in addition to 100-mg magnesium sulfate, in a total volume of 4 ml in both groups. The primary outcome is onset, duration, and intensity of sensory and motor blockade. The secondary outcomes are hemodynamic stability, duration of postoperative analgesia, and complications. Results The onset of sensory and motor blockade was significantly faster and of prolonged duration in dexmedetomidine group than magnesium sulfate group (P<0.001). The duration of postoperative analgesia was significantly prolonged in dexmedetomidine group (P<0.001). Regarding hemodynamic and complications, there were no significant differences between both groups (P˃0.005). Conclusion Addition of dexmedetomidine to intrathecal bupivacaine appears to be superior to magnesium sulfate as it produce faster onset and prolongs the duration of sensory and motor blockade and postoperative analgesia. 
546 |a EN 
690 |a dexmedetomidine 
690 |a intrathecal bupivacaine 
690 |a magnesium sulfate 
690 |a total abdominal hysterectomy 
690 |a Internal medicine 
690 |a RC31-1245 
655 7 |a article  |2 local 
786 0 |n Al-Azhar Assiut Medical Journal, Vol 18, Iss 1, Pp 40-45 (2020) 
787 0 |n http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2020;volume=18;issue=1;spage=40;epage=45;aulast=Farhat 
787 0 |n https://doaj.org/toc/1687-1693 
856 4 1 |u https://doaj.org/article/538ff62d9c1d44a096585d14517aaedb  |z Connect to this object online.